Germany· DE-A57-c4813623c2b4ecf4
Erypo Fs
A epoetin alfa product containing epoetin alfa, registered in Germany by Janssen-Cilag Gmbh. The same ATC class is registered in 2 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Epoetin alfa is registered in 2 of 19 countries.
Countries holding a registration under ATC EPOETIN ALFA (epoetin alfa), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
Epoetin alfa · ATC EPOETIN ALFA
2 / 19 countries
- Germany
- United Kingdom
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Epoetin Alfa
- Manufacturer
- Janssen-Cilag Gmbh
- Country
- Germany (DE)
- ATC code
- EPOETIN ALFA
- ATC class
- EPOETIN ALFA
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Epoetin alfa in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaABSEAMEDMedice Arzneimittel Pütter GmbH & Co. KG, Iserlohn
- FinlandAbseamedMedice Arzneimittel Pütter GmbH & Co. KG
- BelgiumAbseamed 1000 IU/0.5 mlMedice Arzneimittel Pütter
- IcelandAbseamedMedice Arzneimittel Pütter GmbH & Co. KG*
- NetherlandsAbseamed 10.000 IE/1 ml oplossing voor injectie in een voorgevulde spuitMedice Arzneimittel Pütter GmbH & Co. KG
- SwedenAbseamed 10 000 IE/ 1 ml Injektionsvätska, lösning i förfylld sprutaMedice Arzneimittel Pütter GmbH & Co. KG
- PolandAbseamedMedice Arzneimittel Puetter GmbH & Co. KG
- IrelandAbseamed 1 000 IU/0.5 mL solution for injection in a pre-filled syringeMedice Arzneimittel Putter GmbH & Co. K.G
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Erypo
- Belgium · Eprex
- Czechia · Eprex
- Spain · Eprex
- France · Eprex
- United Kingdom (Northern Ireland) · Eprex
- Greece · Eprex
- Iceland · Abseamed, Binocrit
- Italy · Eprex
- Liechtenstein · Binocrit, Epoetin Alfa Hexal
- Luxembourg · Eprex
- Netherlands · Eprex
- Norway · Abseamed, Binocrit
- Portugal · Eprex
- Slovenia · Eprex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/12de8323-d2de-4023-89a7-67c517089a09 GET /v1/drugs/12de8323-d2de-4023-89a7-67c517089a09?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use ,Subcutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Epoetin Alfa",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about epoetin alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.